Cargando…

Long-term effects of the gait treatment using a wearable cyborg hybrid assistive limb in a patient with spinal and bulbar muscular atrophy: a case report with 5 years of follow-up

BACKGROUND: Spinal and bulbar muscular atrophy (SBMA) is a progressive neuromuscular degenerative disease characterized by the degeneration of lower motor neurons in the spinal cord and brainstem and neurogenic atrophy of the skeletal muscle. Although the short-term effectiveness of gait treatment u...

Descripción completa

Detalles Bibliográficos
Autores principales: Iijima, Kensuke, Watanabe, Hiroki, Nakashiro, Yuichi, Iida, Yuki, Nonaka, Michio, Moriwaka, Fumio, Hamada, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285061/
https://www.ncbi.nlm.nih.gov/pubmed/37360345
http://dx.doi.org/10.3389/fneur.2023.1143820
_version_ 1785061528574099456
author Iijima, Kensuke
Watanabe, Hiroki
Nakashiro, Yuichi
Iida, Yuki
Nonaka, Michio
Moriwaka, Fumio
Hamada, Shinsuke
author_facet Iijima, Kensuke
Watanabe, Hiroki
Nakashiro, Yuichi
Iida, Yuki
Nonaka, Michio
Moriwaka, Fumio
Hamada, Shinsuke
author_sort Iijima, Kensuke
collection PubMed
description BACKGROUND: Spinal and bulbar muscular atrophy (SBMA) is a progressive neuromuscular degenerative disease characterized by the degeneration of lower motor neurons in the spinal cord and brainstem and neurogenic atrophy of the skeletal muscle. Although the short-term effectiveness of gait treatment using a wearable cyborg hybrid assistive limb (HAL) has been demonstrated for the rehabilitation of patients with SBMA, the long-term effects of this treatment are unclear. Thus, this study aimed to investigate the long-term effects of the continued gait treatment with HAL in a patient with SBMA. RESULTS: A 68-year-old man with SBMA had lower limb muscle weakness and atrophy, gait asymmetry, and decreased walking endurance. The patient performed nine courses of HAL gait treatment (as one course three times per week for 3 weeks, totaling nine times) for ~5 years. The patient performed HAL gait treatment to improve gait symmetry and endurance. A physical therapist adjusted HAL based on the gait analysis and physical function of the patient. Outcome measurements, such as 2-min walking distance (2MWD), 10-meter walking test (maximal walking speed, step length, cadence, and gait symmetry), muscle strength, Revised Amyotrophic Lateral Sclerosis Functional Assessment Scale (ALSFRS-R), and patient-reported outcomes, were evaluated immediately before and after gait treatment with HAL for each course. 2MWD improved from 94 m to 101.8 m, and the ALSFRS-R gait items remained unchanged (score 3) for approximately 5 years. The patient could maintain walking ability in terms of gait symmetry, walking endurance, and independence walking despite disease progression during HAL treatment. CONCLUSION: The long-term gait treatment with HAL in a patient with SBMA may contribute to the maintenance and improvement of the gait endurance and ability to perform activities of daily living. The cybernics treatment using HAL may enable patients to relearn correct gait movements. The gait analysis and physical function assessment by a physical therapist might be important to maximize the benefits of HAL treatment.
format Online
Article
Text
id pubmed-10285061
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102850612023-06-23 Long-term effects of the gait treatment using a wearable cyborg hybrid assistive limb in a patient with spinal and bulbar muscular atrophy: a case report with 5 years of follow-up Iijima, Kensuke Watanabe, Hiroki Nakashiro, Yuichi Iida, Yuki Nonaka, Michio Moriwaka, Fumio Hamada, Shinsuke Front Neurol Neurology BACKGROUND: Spinal and bulbar muscular atrophy (SBMA) is a progressive neuromuscular degenerative disease characterized by the degeneration of lower motor neurons in the spinal cord and brainstem and neurogenic atrophy of the skeletal muscle. Although the short-term effectiveness of gait treatment using a wearable cyborg hybrid assistive limb (HAL) has been demonstrated for the rehabilitation of patients with SBMA, the long-term effects of this treatment are unclear. Thus, this study aimed to investigate the long-term effects of the continued gait treatment with HAL in a patient with SBMA. RESULTS: A 68-year-old man with SBMA had lower limb muscle weakness and atrophy, gait asymmetry, and decreased walking endurance. The patient performed nine courses of HAL gait treatment (as one course three times per week for 3 weeks, totaling nine times) for ~5 years. The patient performed HAL gait treatment to improve gait symmetry and endurance. A physical therapist adjusted HAL based on the gait analysis and physical function of the patient. Outcome measurements, such as 2-min walking distance (2MWD), 10-meter walking test (maximal walking speed, step length, cadence, and gait symmetry), muscle strength, Revised Amyotrophic Lateral Sclerosis Functional Assessment Scale (ALSFRS-R), and patient-reported outcomes, were evaluated immediately before and after gait treatment with HAL for each course. 2MWD improved from 94 m to 101.8 m, and the ALSFRS-R gait items remained unchanged (score 3) for approximately 5 years. The patient could maintain walking ability in terms of gait symmetry, walking endurance, and independence walking despite disease progression during HAL treatment. CONCLUSION: The long-term gait treatment with HAL in a patient with SBMA may contribute to the maintenance and improvement of the gait endurance and ability to perform activities of daily living. The cybernics treatment using HAL may enable patients to relearn correct gait movements. The gait analysis and physical function assessment by a physical therapist might be important to maximize the benefits of HAL treatment. Frontiers Media S.A. 2023-06-08 /pmc/articles/PMC10285061/ /pubmed/37360345 http://dx.doi.org/10.3389/fneur.2023.1143820 Text en Copyright © 2023 Iijima, Watanabe, Nakashiro, Iida, Nonaka, Moriwaka and Hamada. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Iijima, Kensuke
Watanabe, Hiroki
Nakashiro, Yuichi
Iida, Yuki
Nonaka, Michio
Moriwaka, Fumio
Hamada, Shinsuke
Long-term effects of the gait treatment using a wearable cyborg hybrid assistive limb in a patient with spinal and bulbar muscular atrophy: a case report with 5 years of follow-up
title Long-term effects of the gait treatment using a wearable cyborg hybrid assistive limb in a patient with spinal and bulbar muscular atrophy: a case report with 5 years of follow-up
title_full Long-term effects of the gait treatment using a wearable cyborg hybrid assistive limb in a patient with spinal and bulbar muscular atrophy: a case report with 5 years of follow-up
title_fullStr Long-term effects of the gait treatment using a wearable cyborg hybrid assistive limb in a patient with spinal and bulbar muscular atrophy: a case report with 5 years of follow-up
title_full_unstemmed Long-term effects of the gait treatment using a wearable cyborg hybrid assistive limb in a patient with spinal and bulbar muscular atrophy: a case report with 5 years of follow-up
title_short Long-term effects of the gait treatment using a wearable cyborg hybrid assistive limb in a patient with spinal and bulbar muscular atrophy: a case report with 5 years of follow-up
title_sort long-term effects of the gait treatment using a wearable cyborg hybrid assistive limb in a patient with spinal and bulbar muscular atrophy: a case report with 5 years of follow-up
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285061/
https://www.ncbi.nlm.nih.gov/pubmed/37360345
http://dx.doi.org/10.3389/fneur.2023.1143820
work_keys_str_mv AT iijimakensuke longtermeffectsofthegaittreatmentusingawearablecyborghybridassistivelimbinapatientwithspinalandbulbarmuscularatrophyacasereportwith5yearsoffollowup
AT watanabehiroki longtermeffectsofthegaittreatmentusingawearablecyborghybridassistivelimbinapatientwithspinalandbulbarmuscularatrophyacasereportwith5yearsoffollowup
AT nakashiroyuichi longtermeffectsofthegaittreatmentusingawearablecyborghybridassistivelimbinapatientwithspinalandbulbarmuscularatrophyacasereportwith5yearsoffollowup
AT iidayuki longtermeffectsofthegaittreatmentusingawearablecyborghybridassistivelimbinapatientwithspinalandbulbarmuscularatrophyacasereportwith5yearsoffollowup
AT nonakamichio longtermeffectsofthegaittreatmentusingawearablecyborghybridassistivelimbinapatientwithspinalandbulbarmuscularatrophyacasereportwith5yearsoffollowup
AT moriwakafumio longtermeffectsofthegaittreatmentusingawearablecyborghybridassistivelimbinapatientwithspinalandbulbarmuscularatrophyacasereportwith5yearsoffollowup
AT hamadashinsuke longtermeffectsofthegaittreatmentusingawearablecyborghybridassistivelimbinapatientwithspinalandbulbarmuscularatrophyacasereportwith5yearsoffollowup